miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53

被引:11
作者
Zhou, Ping [1 ]
Dong, He [1 ]
He, Shuqian [1 ]
Fang, Lei [1 ]
Jiang, Nan [2 ]
Sun, Qing [1 ]
机构
[1] Shandong Univ, Dept Pathol, Qianfoshan Hosp, 16766 Jingshi Rd, Jinan 250014, Shandong, Peoples R China
[2] Shandong Univ, Sch Med, Dept Pathol, Jinan 250014, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
esophageal squamous cell carcinoma; microRNA-612; TP53; lymph node metastasis; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; MIR-612; SUPPRESSES; GENE-EXPRESSION; DOWN-REGULATION; CANCER; MICRORNA; PROFILES; P53; SURVIVAL;
D O I
10.3892/mmr.2017.6808
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MicroRNAs (miRNAs) serve an important role in the regulation of gene expression. In the present study, differential expressions of miRNAs were compared between esophageal squamous cell carcinoma (ESCC) tissues and normal esophageal tissues. In combination with miRNA target prediction databases, a significantly increased expression of miR-612 was discovered in ESCC. The relationship between miR-612 and TP53 gene expression and their roles in ESCC invasion and metastasis was further studied by reverse transcription-quantitative polymerase chain reaction and western blotting in EC109 cells and cancer tissues. The EC109 cell invasion and migration were significantly reduced after miR-612 expression was inhibited. The levels of wild type TP53 protein and mRNA were lower in ESCC tissues compared to the normal esophageal epithelium. In addition, the mRNA and protein expression levels were reported as downregulated further in tumors with metastasis than in tumors without. In conclusion, miR-612 is identified as associated with ESCC development and metastasis, likely through the regulation of TP53 expression, which could be a potential therapeutic target.
引用
收藏
页码:1855 / 1863
页数:9
相关论文
共 50 条
  • [41] The Association of TP53, BCL2, BAX and NOXA SNPs and Laryngeal Squamous Cell Carcinoma Development
    Jakstas, Tomas
    Bartnykaite, Agne
    Padervinskis, Evaldas
    Vegiene, Aurelija
    Juozaityte, Elona
    Uloza, Virgilijus
    Ugenskiene, Rasa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [42] TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma
    Dongre, Harsh Nitin
    Elnour, Rammah
    Tornaas, Stian
    Fromreide, Siren
    Thomsen, Liv Cecilie Vestrheim
    Kolseth, Ingrid Benedicte Moss
    Nginamau, Elisabeth Sivy
    Johannessen, Anne Christine
    Vintermyr, Olav Karsten
    Costea, Daniela Elena
    Bjorge, Line
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2024, 103 (01) : 165 - 175
  • [43] Non-disruptive mutation in TP53 DNA-binding domain is a beneficial factor of esophageal squamous cell carcinoma
    Huang, Minran
    Jin, Jiaoyue
    Zhang, Fanrong
    Wu, Yingxue
    Xu, Chenyang
    Ying, Lisha
    Su, Dan
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (06)
  • [44] TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV-associated oral squamous cell carcinoma
    Shi, Yewen
    Ren, Xiaoyong
    Cao, Shaolong
    Chen, Xi
    Yuan, Bo
    da Costa, Fabio Henrique Brasil
    Rosario, Alanis E. Rodriguez
    Corona, Arnoldo
    Michikawa, Chieko
    Veeramachaneni, Ratna
    Osman, Abdullah A.
    Xie, Tongxin
    Wang, Wenyi
    Sikora, Andrew G.
    Myers, Jeffrey N.
    Rangel, Roberto
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [45] Overexpression of WRAP53 Is Associated with Development and Progression of Esophageal Squamous Cell Carcinoma
    Rao, Xuguang
    Huang, Daofu
    Sui, Xuxia
    Liu, Gefei
    Song, Xuhong
    Xie, Jinglian
    Huang, Dongyang
    PLOS ONE, 2014, 9 (03):
  • [46] Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis
    Wang, Bin
    Wang, Dan
    Zhang, Deqiang
    Li, Aijun
    Liu, Dawei
    Liu, Hu
    Jin, Hai
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2010, 19 (04) : 299 - 307
  • [47] Overexpression of TP53 mutation-associated microRNA-182 promotes tumor cell proliferation and migration in head and neck squamous cell carcinoma
    Wang, Li
    Jiang, Haihua
    Li, Wencai
    Jia, Chuanliang
    Zhang, Hua
    Sun, Yan
    Chen, Xiumei
    Song, Xicheng
    ARCHIVES OF ORAL BIOLOGY, 2017, 73 : 105 - 112
  • [48] Development of a Novel Serum Exosomal MicroRNA Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma
    Liu, Tong
    Du, Lu-Tao
    Wang, Yun-Shan
    Gao, Shan-Yu
    Li, Juan
    Li, Pei-Long
    Sun, Zhao-Wei
    Binang, Helen
    Wang, Chuan-Xin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection
    Eicheler, W
    Zips, D
    Dörfler, A
    Grénman, R
    Baumann, M
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2002, 50 (02) : 197 - 204
  • [50] Expression of TP53 in oral squamous cell carcinoma and its correlation with adverse histopathological features
    Giri, Ranjana
    Hota, Subhransu Kumar
    Sahu, Subrat Kumar
    Senapati, Urmila
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 278 - 282